Loading Page
Dr. Shlomo Melmed, MB, MD is an endocrinologist in Los Angeles, CA specializing in endocrinology diabetes & metabolism. He graduated from University of Cape Town Faculty of Health Sciences in 1970 and has 56 years of experience. Dr. Shlomo Melmed, MB, MD is affiliated with Cedars-Sinai.
Dr. Shlomo Melmed, MB, MD graduated from University of Cape Town Faculty of Health Sciences in 1970. He is certified by the Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine and has a state license in California.
Medical School: University of Cape Town Faculty of Health Sciences (1970)
Board Certification: Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine
Licensed In: California
Dr. Shlomo Melmed, MB, MD appears to accept the following insurance providers: CIGNA PPO, CIGNA HMO, MultiPlan PPO, MultiPlan, United Healthcare PPO, Coventry PPO, United Healthcare HMO, Railroad Medicare, United Healthcare, Anthem Blue Cross HMO, Anthem Blue Cross PPO, Humana, Cigna, Medi-Cal, Anthem, Health Net PPO, Health Net HMO, HealthSmart PPO, HealthSmart, Optima Health, First Health, Beech Street, Aetna PPO, Aetna HMO, Aetna ACO, Aids Healthcare Foundation HMO, Gold Coast PPO, Aids Healthcare Foundation PPO, Blue Shield California HMO, Health Net MAH, Aids Healthcare Foundation MAH, CareMore HMO, Blue Shield California PPO, Medicare MCR, Blue Shield California MAH and CareMore MAH.
According to our sources, Dr. Shlomo Melmed, MB, MD accepts the following insurance providers:
Dr. Shlomo Melmed, MB, MD does not have any reviews yet, be the first to leave a review of Dr. Shlomo Melmed, MB, MD here: Leave a Review
These charts describe general payments received by Dr. Shlomo Melmed, MB, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$116,225
$116,225 |
||||||
|
$93,101
SOMAVERT $79,744 |
GENOTROPIN $13,125 |
$232 |
||||
|
$91,167
SIGNIFOR $46,929 |
SANDOSTATIN $40,418 |
NON BRAND $40 |
$3,780 |
|||
|
$42,667
Somatuline Depot 120mg-.5ml $38,839 |
Somatuline Depot $3,678 |
$150 |
||||
|
$17,442
MYCAPSSA $17,442 |
||||||
|
$58,595
Somatuline Depot $8,550 |
Non-Covered Product $7,074 |
Norditropin $5,940 |
LCI699A $3,720 |
ISTURISA $3,342 |
Other $29,969 |
| $226,447 | |
| $100,472 | |
| $73,740 | |
| $6,050 | |
| $5,424 | |
| $7,065 |
Dr. Shlomo Melmed, MB, MD has received 116 research payments totaling $5,944,099.
The research focus of Dr Shlomo Melmed is molecular pathogenesis of pituitary tumors and pituitary receptor signaling. He employs molecular, cellular, transgenic animal and human tissue models to understand the biology of these commonly encountered hormone-secreting adenomas. He tests pituitary receptor signaling to develop novel peptide analog treatments for these tumors secreting growth hormone, prolactin, ACTH or gonadotropins.
